These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31978788)

  • 1. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
    Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
    J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
    Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
    J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
    Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R
    Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor.
    Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G
    J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecularly self-assembled nano-twin drug for reversing multidrug resistance.
    Wu C; Xu L; Shi L; Gao X; Li J; Zhu X; Zhang C
    Biomater Sci; 2018 Jul; 6(8):2261-2269. PubMed ID: 29999073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
    Ni R; Zhu J; Xu Z; Chen Y
    J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
    Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M
    Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
    Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C
    Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance.
    Cheng X; Lv X; Xu J; Zheng Y; Wang X; Tang R
    Eur J Pharm Sci; 2020 Apr; 146():105275. PubMed ID: 32087259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer.
    Zeng X; Cheng X; Zheng Y; Yan G; Wang X; Wang J; Tang R
    Carbohydr Polym; 2020 Jun; 237():116139. PubMed ID: 32241443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Y
    Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
    Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles.
    Liu S; Li R; Qian J; Sun J; Li G; Shen J; Xie Y
    Mol Pharm; 2020 Apr; 17(4):1415-1427. PubMed ID: 32159961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
    Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells.
    Zhang X; Chen W; Bai J; Jin L; Kang X; Zhang H; Wang Z
    Aging (Albany NY); 2020 May; 12(9):8289-8300. PubMed ID: 32396524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
    Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
    Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
    Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.